APO Research
Talk to an analyst

APO RESEARCH · REPORT

Functional Dyspepsia Drug

Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.

Selected research

Industry Growth & Trends

Global Functional Dyspepsia Drug Industry Growth and Trends Forecast to 2032

29 December 2025109 pages

Choose your research edition.

Industry ResearchFunctional Dyspepsia Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Functional Dyspepsia Drug Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Functional Dyspepsia Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Functional Dyspepsia Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Functional Dyspepsia Drug Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.

North America is the largest consumer of Functional Dyspepsia Drug in global market, with a consumption market share of 38.71% in 2019. Market is not concentrated.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Functional Dyspepsia Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Functional Dyspepsia Drug market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Functional Dyspepsia Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Functional Dyspepsia Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Functional Dyspepsia Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Functional Dyspepsia Drug Market by Company

Bayer

Sumitomo

Cadila Pharmaceuticals

Teva

Johnson & Johnson

Pfizer

Sanofi

AstraZeneca

Jiangsu Aosaikang Pharma

Eisai

Kyowa Kirin Pharmaceuticals

Hanmi Pharm

Functional Dyspepsia Drug Segment by Type

Prokinetic Drugs

Gastric Antisecretory Drugs

Others

Functional Dyspepsia Drug Segment by Application

Hospitals

Drugstores

Functional Dyspepsia Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Functional Dyspepsia Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Functional Dyspepsia Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Functional Dyspepsia Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Functional Dyspepsia Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Functional Dyspepsia Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Prokinetic Drugs Table 2. Major Company of Gastric Antisecretory Drugs Table 3. Major Company of Others Table 4. Global Functional Dyspepsia Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Functional Dyspepsia Drug Sales by Type (2021-2026) & (M Units) Table 6. Global Functional Dyspepsia Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Functional Dyspepsia Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Functional Dyspepsia Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Functional Dyspepsia Drug Price by Type (2021-2026) & (US$/Unit) Table 10. Global Functional Dyspepsia Drug Sales by Type (2027-2032) & (M Units) Table 11. Global Functional Dyspepsia Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Functional Dyspepsia Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Functional Dyspepsia Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Functional Dyspepsia Drug Price by Type (2027-2032) & (US$/Unit) Table 15. North America Functional Dyspepsia Drug Sales by Type (2021-2026) & (M Units) Table 16. North America Functional Dyspepsia Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Functional Dyspepsia Drug Sales by Type (2021-2026) & (M Units) Table 18. Europe Functional Dyspepsia Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Functional Dyspepsia Drug Sales by Type (2021-2026) & (M Units) Table 20. Asia-Pacific Functional Dyspepsia Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Functional Dyspepsia Drug Sales by Type (2021-2026) & (M Units) Table 22. Latin America Functional Dyspepsia Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Functional Dyspepsia Drug Sales by Type (2021-2026) & (M Units) Table 24. Middle East and Africa Functional Dyspepsia Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Functional Dyspepsia Drug Industry Trends Table 26. Functional Dyspepsia Drug Industry Drivers Table 27. Functional Dyspepsia Drug Industry Opportunities and Challenges Table 28. Functional Dyspepsia Drug Industry Restraints Table 29. Global Functional Dyspepsia Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Functional Dyspepsia Drug Revenue Market Share by Company (2021-2026) Table 31. Global Functional Dyspepsia Drug Sales by Company (2021-2026) & (M Units) Table 32. Global Functional Dyspepsia Drug Sales Share by Company (2021-2026) Table 33. Global Functional Dyspepsia Drug Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Functional Dyspepsia Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Functional Dyspepsia Drug Major Company Production Sites and Headquarters Table 36. Global Functional Dyspepsia Drug Company, Product Type & Application Table 37. Global Functional Dyspepsia Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Functional Dyspepsia Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Functional Dyspepsia Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Functional Dyspepsia Drug Sales by Region (2021-2026) & (M Units) Table 42. Global Functional Dyspepsia Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Functional Dyspepsia Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Functional Dyspepsia Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Functional Dyspepsia Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Functional Dyspepsia Drug Sales by Region (2027-2032) & (M Units) Table 47. Global Functional Dyspepsia Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Functional Dyspepsia Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Functional Dyspepsia Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Functional Dyspepsia Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Functional Dyspepsia Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Functional Dyspepsia Drug Sales by Application (2021-2026) & (M Units) Table 53. Global Functional Dyspepsia Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Functional Dyspepsia Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Functional Dyspepsia Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Functional Dyspepsia Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Functional Dyspepsia Drug Sales by Application (2027-2032) & (M Units) Table 58. Global Functional Dyspepsia Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Functional Dyspepsia Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Functional Dyspepsia Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Functional Dyspepsia Drug Price by Application (2027-2032) & (US$/Unit) Table 62. North America Functional Dyspepsia Drug Sales by Application (2021-2026) & (M Units) Table 63. North America Functional Dyspepsia Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Functional Dyspepsia Drug Sales by Application (2021-2026) & (M Units) Table 65. Europe Functional Dyspepsia Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Functional Dyspepsia Drug Sales by Application (2021-2026) & (M Units) Table 67. Asia-Pacific Functional Dyspepsia Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Functional Dyspepsia Drug Sales by Application (2021-2026) & (M Units) Table 69. Latin America Functional Dyspepsia Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Functional Dyspepsia Drug Sales by Application (2021-2026) & (M Units) Table 71. Middle East and Africa Functional Dyspepsia Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Bayer Company Information Table 73. Bayer Business Overview Table 74. Bayer Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Bayer Functional Dyspepsia Drug Product Portfolio Table 76. Bayer Recent Development Table 77. Sumitomo Company Information Table 78. Sumitomo Business Overview Table 79. Sumitomo Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sumitomo Functional Dyspepsia Drug Product Portfolio Table 81. Sumitomo Recent Development Table 82. Cadila Pharmaceuticals Company Information Table 83. Cadila Pharmaceuticals Business Overview Table 84. Cadila Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Cadila Pharmaceuticals Functional Dyspepsia Drug Product Portfolio Table 86. Cadila Pharmaceuticals Recent Development Table 87. Teva Company Information Table 88. Teva Business Overview Table 89. Teva Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Teva Functional Dyspepsia Drug Product Portfolio Table 91. Teva Recent Development Table 92. Johnson & Johnson Company Information Table 93. Johnson & Johnson Business Overview Table 94. Johnson & Johnson Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Johnson & Johnson Functional Dyspepsia Drug Product Portfolio Table 96. Johnson & Johnson Recent Development Table 97. Pfizer Company Information Table 98. Pfizer Business Overview Table 99. Pfizer Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Pfizer Functional Dyspepsia Drug Product Portfolio Table 101. Pfizer Recent Development Table 102. Sanofi Company Information Table 103. Sanofi Business Overview Table 104. Sanofi Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Sanofi Functional Dyspepsia Drug Product Portfolio Table 106. Sanofi Recent Development Table 107. AstraZeneca Company Information Table 108. AstraZeneca Business Overview Table 109. AstraZeneca Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. AstraZeneca Functional Dyspepsia Drug Product Portfolio Table 111. AstraZeneca Recent Development Table 112. Jiangsu Aosaikang Pharma Company Information Table 113. Jiangsu Aosaikang Pharma Business Overview Table 114. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Portfolio Table 116. Jiangsu Aosaikang Pharma Recent Development Table 117. Eisai Company Information Table 118. Eisai Business Overview Table 119. Eisai Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Eisai Functional Dyspepsia Drug Product Portfolio Table 121. Eisai Recent Development Table 122. Kyowa Kirin Pharmaceuticals Company Information Table 123. Kyowa Kirin Pharmaceuticals Business Overview Table 124. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product Portfolio Table 126. Kyowa Kirin Pharmaceuticals Recent Development Table 127. Hanmi Pharm Company Information Table 128. Hanmi Pharm Business Overview Table 129. Hanmi Pharm Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Hanmi Pharm Functional Dyspepsia Drug Product Portfolio Table 131. Hanmi Pharm Recent Development Table 132. North America Functional Dyspepsia Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 133. North America Functional Dyspepsia Drug Sales by Country (2021-2026) & (M Units) Table 134. North America Functional Dyspepsia Drug Sales Market Share by Country (2021-2026) Table 135. North America Functional Dyspepsia Drug Sales Forecast by Country (2027-2032) & (M Units) Table 136. North America Functional Dyspepsia Drug Sales Market Share Forecast by Country (2027-2032) Table 137. North America Functional Dyspepsia Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. North America Functional Dyspepsia Drug Market Size by Country (2021-2026) & (US$ Million) Table 139. North America Functional Dyspepsia Drug Market Share by Country (2021-2026) Table 140. North America Functional Dyspepsia Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. North America Functional Dyspepsia Drug Market Share Forecast by Country (2027-2032) Table 142. Europe Functional Dyspepsia Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 143. Europe Functional Dyspepsia Drug Sales by Country (2021-2026) & (M Units) Table 144. Europe Functional Dyspepsia Drug Sales Market Share by Country (2021-2026) Table 145. Europe Functional Dyspepsia Drug Sales Forecast by Country (2027-2032) & (M Units) Table 146. Europe Functional Dyspepsia Drug Sales Market Share Forecast by Country (2027-2032) Table 147. Europe Functional Dyspepsia Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Europe Functional Dyspepsia Drug Market Size by Country (2021-2026) & (US$ Million) Table 149. Europe Functional Dyspepsia Drug Market Share by Country (2021-2026) Table 150. Europe Functional Dyspepsia Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Europe Functional Dyspepsia Drug Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Functional Dyspepsia Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Functional Dyspepsia Drug Sales by Country (2021-2026) & (M Units) Table 154. Asia-Pacific Functional Dyspepsia Drug Sales Market Share by Country (2021-2026) Table 155. Asia-Pacific Functional Dyspepsia Drug Sales Forecast by Country (2027-2032) & (M Units) Table 156. Asia-Pacific Functional Dyspepsia Drug Sales Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Functional Dyspepsia Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Functional Dyspepsia Drug Market Size by Country (2021-2026) & (US$ Million) Table 159. Asia-Pacific Functional Dyspepsia Drug Market Share by Country (2021-2026) Table 160. Asia-Pacific Functional Dyspepsia Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Asia-Pacific Functional Dyspepsia Drug Market Share Forecast by Country (2027-2032) Table 162. Latin America Functional Dyspepsia Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 163. Latin America Functional Dyspepsia Drug Sales by Country (2021-2026) & (M Units) Table 164. Latin America Functional Dyspepsia Drug Sales Market Share by Country (2021-2026) Table 165. Latin America Functional Dyspepsia Drug Sales Forecast by Country (2027-2032) & (M Units) Table 166. Latin America Functional Dyspepsia Drug Sales Market Share Forecast by Country (2027-2032) Table 167. Latin America Functional Dyspepsia Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Latin America Functional Dyspepsia Drug Market Size by Country (2021-2026) & (US$ Million) Table 169. Latin America Functional Dyspepsia Drug Market Share by Country (2021-2026) Table 170. Latin America Functional Dyspepsia Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Latin America Functional Dyspepsia Drug Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Functional Dyspepsia Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Functional Dyspepsia Drug Sales by Country (2021-2026) & (M Units) Table 174. Middle East and Africa Functional Dyspepsia Drug Sales Market Share by Country (2021-2026) Table 175. Middle East and Africa Functional Dyspepsia Drug Sales Forecast by Country (2027-2032) & (M Units) Table 176. Middle East and Africa Functional Dyspepsia Drug Sales Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Functional Dyspepsia Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Functional Dyspepsia Drug Market Size by Country (2021-2026) & (US$ Million) Table 179. Middle East and Africa Functional Dyspepsia Drug Market Share by Country (2021-2026) Table 180. Middle East and Africa Functional Dyspepsia Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Middle East and Africa Functional Dyspepsia Drug Market Share Forecast by Country (2027-2032) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Functional Dyspepsia Drug Distributors List Table 185. Functional Dyspepsia Drug Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. Functional Dyspepsia Drug Image Figure 2. Global Functional Dyspepsia Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Functional Dyspepsia Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Functional Dyspepsia Drug Sales (2021-2032) & (M Units) Figure 5. Prokinetic Drugs Image Figure 6. Global Prokinetic Drugs Sales YoY Growth (2021-2032) & (M Units) Figure 7. Gastric Antisecretory Drugs Image Figure 8. Global Gastric Antisecretory Drugs Sales YoY Growth (2021-2032) & (M Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 11. Global Functional Dyspepsia Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Functional Dyspepsia Drug Market Share by Type 2025 VS 2032 Figure 13. North America Functional Dyspepsia Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Functional Dyspepsia Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Functional Dyspepsia Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Functional Dyspepsia Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Functional Dyspepsia Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Functional Dyspepsia Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Functional Dyspepsia Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Functional Dyspepsia Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Functional Dyspepsia Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Functional Dyspepsia Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Functional Dyspepsia Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (M Units) Figure 27. Drugstores Image Figure 28. Global Drugstores Sales YoY Growth (2021-2032) & (M Units) Figure 29. Global Functional Dyspepsia Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Functional Dyspepsia Drug Market Share by Application 2025 VS 2032 Figure 31. North America Functional Dyspepsia Drug Sales Market Share in Volume by Application in 2025 Figure 32. North America Functional Dyspepsia Drug Sales Market Share in Value by Application in 2025 Figure 33. Europe Functional Dyspepsia Drug Sales Market Share in Volume by Application in 2025 Figure 34. Europe Functional Dyspepsia Drug Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Functional Dyspepsia Drug Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Functional Dyspepsia Drug Sales Market Share in Value by Application in 2025 Figure 37. Latin America Functional Dyspepsia Drug Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Functional Dyspepsia Drug Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Functional Dyspepsia Drug Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Functional Dyspepsia Drug Sales Market Share in Value by Application in 2025 Figure 41. North America Functional Dyspepsia Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 42. North America Functional Dyspepsia Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Functional Dyspepsia Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Functional Dyspepsia Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Functional Dyspepsia Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 46. Europe Functional Dyspepsia Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Functional Dyspepsia Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Functional Dyspepsia Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Functional Dyspepsia Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 50. Asia-Pacific Functional Dyspepsia Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Functional Dyspepsia Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Functional Dyspepsia Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Functional Dyspepsia Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 54. Latin America Functional Dyspepsia Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Functional Dyspepsia Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Functional Dyspepsia Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Functional Dyspepsia Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 58. Middle East and Africa Functional Dyspepsia Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Functional Dyspepsia Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Functional Dyspepsia Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Functional Dyspepsia Drug Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Functional Dyspepsia Drug Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Prokinetic Drugs
  • Gastric Antisecretory Drugs
  • Others
Applications
  • Hospitals
  • Drugstores
Companies covered
  • Bayer
  • Sumitomo
  • Cadila Pharmaceuticals
  • Teva
  • Johnson & Johnson
  • Pfizer
  • Sanofi
  • AstraZeneca
  • Jiangsu Aosaikang Pharma
  • Eisai
  • Kyowa Kirin Pharmaceuticals
  • Hanmi Pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Functional Dyspepsia Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Functional Dyspepsia Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Functional Dyspepsia Drug Market by Type
  6. 1.3.1 Prokinetic Drugs
  7. 1.3.2 Gastric Antisecretory Drugs
  8. 1.3.3 Others
  9. 1.4 Global Functional Dyspepsia Drug Market Size by Type
  10. 1.4.1 Global Functional Dyspepsia Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Functional Dyspepsia Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Functional Dyspepsia Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Functional Dyspepsia Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Functional Dyspepsia Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Functional Dyspepsia Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Functional Dyspepsia Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Functional Dyspepsia Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Functional Dyspepsia Drug Industry Trends
  2. 2.2 Functional Dyspepsia Drug Industry Drivers
  3. 2.3 Functional Dyspepsia Drug Industry Opportunities and Challenges
  4. 2.4 Functional Dyspepsia Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Functional Dyspepsia Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Functional Dyspepsia Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Functional Dyspepsia Drug Price (2021-2026)
  4. 3.4 Global Functional Dyspepsia Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Functional Dyspepsia Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Functional Dyspepsia Drug Company, Product Type & Application
  7. 3.7 Global Functional Dyspepsia Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Functional Dyspepsia Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Functional Dyspepsia Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Functional Dyspepsia Drug Tier 1, Tier 2, and Tier 3
4 Functional Dyspepsia Drug Regional Status and Outlook
  1. 4.1 Global Functional Dyspepsia Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Functional Dyspepsia Drug Historic Market Size by Region
  3. 4.2.1 Global Functional Dyspepsia Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Functional Dyspepsia Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Functional Dyspepsia Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Functional Dyspepsia Drug Forecasted Market Size by Region
  7. 4.3.1 Global Functional Dyspepsia Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Functional Dyspepsia Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Functional Dyspepsia Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Functional Dyspepsia Drug by Application
  1. 5.1 Functional Dyspepsia Drug Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Drugstores
  4. 5.2 Global Functional Dyspepsia Drug Market Size by Application
  5. 5.2.1 Global Functional Dyspepsia Drug Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Functional Dyspepsia Drug Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Functional Dyspepsia Drug Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Functional Dyspepsia Drug Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Functional Dyspepsia Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Functional Dyspepsia Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Functional Dyspepsia Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Functional Dyspepsia Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bayer
  2. 6.1.1 Bayer Company Information
  3. 6.1.2 Bayer Business Overview
  4. 6.1.3 Bayer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bayer Functional Dyspepsia Drug Product Portfolio
  6. 6.1.5 Bayer Recent Developments
  7. 6.2 Sumitomo
  8. 6.2.1 Sumitomo Company Information
  9. 6.2.2 Sumitomo Business Overview
  10. 6.2.3 Sumitomo Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sumitomo Functional Dyspepsia Drug Product Portfolio
  12. 6.2.5 Sumitomo Recent Developments
  13. 6.3 Cadila Pharmaceuticals
  14. 6.3.1 Cadila Pharmaceuticals Company Information
  15. 6.3.2 Cadila Pharmaceuticals Business Overview
  16. 6.3.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cadila Pharmaceuticals Functional Dyspepsia Drug Product Portfolio
  18. 6.3.5 Cadila Pharmaceuticals Recent Developments
  19. 6.4 Teva
  20. 6.4.1 Teva Company Information
  21. 6.4.2 Teva Business Overview
  22. 6.4.3 Teva Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Teva Functional Dyspepsia Drug Product Portfolio
  24. 6.4.5 Teva Recent Developments
  25. 6.5 Johnson & Johnson
  26. 6.5.1 Johnson & Johnson Company Information
  27. 6.5.2 Johnson & Johnson Business Overview
  28. 6.5.3 Johnson & Johnson Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Johnson & Johnson Functional Dyspepsia Drug Product Portfolio
  30. 6.5.5 Johnson & Johnson Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Functional Dyspepsia Drug Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Sanofi
  38. 6.7.1 Sanofi Company Information
  39. 6.7.2 Sanofi Business Overview
  40. 6.7.3 Sanofi Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sanofi Functional Dyspepsia Drug Product Portfolio
  42. 6.7.5 Sanofi Recent Developments
  43. 6.8 AstraZeneca
  44. 6.8.1 AstraZeneca Company Information
  45. 6.8.2 AstraZeneca Business Overview
  46. 6.8.3 AstraZeneca Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 AstraZeneca Functional Dyspepsia Drug Product Portfolio
  48. 6.8.5 AstraZeneca Recent Developments
  49. 6.9 Jiangsu Aosaikang Pharma
  50. 6.9.1 Jiangsu Aosaikang Pharma Company Information
  51. 6.9.2 Jiangsu Aosaikang Pharma Business Overview
  52. 6.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Portfolio
  54. 6.9.5 Jiangsu Aosaikang Pharma Recent Developments
  55. 6.10 Eisai
  56. 6.10.1 Eisai Company Information
  57. 6.10.2 Eisai Business Overview
  58. 6.10.3 Eisai Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Eisai Functional Dyspepsia Drug Product Portfolio
  60. 6.10.5 Eisai Recent Developments
  61. 6.11 Kyowa Kirin Pharmaceuticals
  62. 6.11.1 Kyowa Kirin Pharmaceuticals Company Information
  63. 6.11.2 Kyowa Kirin Pharmaceuticals Business Overview
  64. 6.11.3 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product Portfolio
  66. 6.11.5 Kyowa Kirin Pharmaceuticals Recent Developments
  67. 6.12 Hanmi Pharm
  68. 6.12.1 Hanmi Pharm Company Information
  69. 6.12.2 Hanmi Pharm Business Overview
  70. 6.12.3 Hanmi Pharm Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hanmi Pharm Functional Dyspepsia Drug Product Portfolio
  72. 6.12.5 Hanmi Pharm Recent Developments
7 North America by Country
  1. 7.1 North America Functional Dyspepsia Drug Sales by Country
  2. 7.1.1 North America Functional Dyspepsia Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Functional Dyspepsia Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Functional Dyspepsia Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Functional Dyspepsia Drug Market Size by Country
  6. 7.2.1 North America Functional Dyspepsia Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Functional Dyspepsia Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Functional Dyspepsia Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Functional Dyspepsia Drug Sales by Country
  2. 8.1.1 Europe Functional Dyspepsia Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Functional Dyspepsia Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Functional Dyspepsia Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Functional Dyspepsia Drug Market Size by Country
  6. 8.2.1 Europe Functional Dyspepsia Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Functional Dyspepsia Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Functional Dyspepsia Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Functional Dyspepsia Drug Sales by Country
  2. 9.1.1 Asia-Pacific Functional Dyspepsia Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Functional Dyspepsia Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Functional Dyspepsia Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Functional Dyspepsia Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Functional Dyspepsia Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Functional Dyspepsia Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Functional Dyspepsia Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Functional Dyspepsia Drug Sales by Country
  2. 10.1.1 South America Functional Dyspepsia Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Functional Dyspepsia Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Functional Dyspepsia Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Functional Dyspepsia Drug Market Size by Country
  6. 10.2.1 South America Functional Dyspepsia Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Functional Dyspepsia Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Functional Dyspepsia Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Functional Dyspepsia Drug Sales by Country
  2. 11.1.1 Middle East and Africa Functional Dyspepsia Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Functional Dyspepsia Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Functional Dyspepsia Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Functional Dyspepsia Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Functional Dyspepsia Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Functional Dyspepsia Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Functional Dyspepsia Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Functional Dyspepsia Drug Value Chain Analysis
  2. 12.1.1 Functional Dyspepsia Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Functional Dyspepsia Drug Production Mode & Process
  7. 12.2 Functional Dyspepsia Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Functional Dyspepsia Drug Distributors
  10. 12.2.3 Functional Dyspepsia Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst